The OmniPod Insulin Management System: The latest innovation in insulin pump therapy

Diabetes Therapy

Volumn 1, Issue 1, 2010, Pages 10-24

  Zisser, Howard C ^a,b  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b University of California   (United States)

Author keywords

continuous glucose monitor; continuous subcutaneous insulin infusion; insulin pump; multiple daily injections; patch pump; wireless pump

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; CALCULATION; CANNULA; CLINICAL TRIAL (TOPIC); CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; HEALTH EDUCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 79953697088     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-010-0004-6     Document Type: Review

References (12)

1. Zisser HC, Jovanovič L. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care. 2006; 29: 2175. Letter.
2. Zisser HC. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care. 2008; 31: 238-239.
3. Zisser HC, Bevier W, Dassau E, Jovanovič L. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technnol. 2010; 4: 98-103.
4. Kane MP, Abelseth JM, Davis K, Hogan E, Hamilton RA. Clinical experience with a tubingfree insulin pump system. Infusystems USA. 2009; 6: 25-27.
5. Dilanni S, Garibotto J. An innovative application of shape memory alloy (SMA) technology yields a novel therapeutic approach to diabetes management. Insulet Corporation. 2006: 12028-AW. Rev 2/04/09.
6. Sirotinin S, George C. Computer-aided learning in insulin pump training. J Diabetes Sci Technnol. 2010; 4: 1022-1026.
7. Lane W, Weinrib SL, Rappaport JM, Przestrzelski T. A prospective trial of U-500 insulin delivered by OmniPod in patients with type 2 diabetes and severe insulin resistance. Endocr Pract. 2010. In press.
8. Dassau E, Palerm CC, Zisser H, Buckingham BA, Jovanovic L, Doyle FJ. In silico evaluation platform for artificial pancreatic beta-cell development-a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther. 2009; 11: 187-194.
9. Bruttomesso D, Farret A, Silvana C, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technnol. 2009; 3: 1014-1021.
10. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technnol. 2009; 3: 1031-1038.
11. AP@Home - bringing the artificial pancreas home. Available at: www. apathome. eu. Accessed August 10, 2010.
12. OmniPod Insulin Management System. Available at: www. myomnipod. com/about-omnipod/faqs. Accessed August 10, 2010.